Literature DB >> 17881243

The PLPp-specific T-cell population promoted by pertussis toxin is characterized by high frequencies of IL-17-producing cells.

Harald H Hofstetter1, Catharina Grau, Mathias Buttmann, Thomas G Forsthuber, Stefanie Gaupp, Klaus V Toyka, Ralf Gold.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is commonly regarded as an animal model of the human disease multiple sclerosis (MS). Pertussis toxin (PTX) is routinely used for EAE induction in mice. Besides opening the blood-brain barrier, it acts as an adjuvant causing strong expansion of antigen-specific cells after coinjection with neuroantigens in IFA. Using an IL-17 ELISPOT assay we developed previously, we investigated the capability of PTX to induce proteolipid protein peptide 139-151(PLPp)-specific Th-17 cells in the immune periphery and in the thymus after coinjection with PLPp/IFA. PTX was found to induce peripheral PLPp-specific Th-17 cells in the draining lymph node and in the spleen, but not in the thymus. Our study indicates a new mechanism by which microbial agents can initiate or maintain autoimmune reactions and supports the growing role in particular for Th-17 cells in organ-specific autoimmune diseases like multiple sclerosis or EAE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17881243     DOI: 10.1016/j.cyto.2007.07.192

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  13 in total

Review 1.  Th17 cytokines and vaccine-induced immunity.

Authors:  Yinyao Lin; Samantha R Slight; Shabaana A Khader
Journal:  Semin Immunopathol       Date:  2010-01-30       Impact factor: 9.623

Review 2.  Targeting NOX enzymes in the central nervous system: therapeutic opportunities.

Authors:  Silvia Sorce; Karl-Heinz Krause; Vincent Jaquet
Journal:  Cell Mol Life Sci       Date:  2012-05-30       Impact factor: 9.261

3.  Interleukin-17--extended features of a key player in multiple sclerosis.

Authors:  Ralf Gold; Fred Lühder
Journal:  Am J Pathol       Date:  2007-12-06       Impact factor: 4.307

4.  Autoimmune responses to brain following stroke.

Authors:  Kyra Becker
Journal:  Transl Stroke Res       Date:  2012-04-05       Impact factor: 6.829

5.  Notch signaling regulates mouse and human Th17 differentiation.

Authors:  Shilpa Keerthivasan; Reem Suleiman; Rebecca Lawlor; Justine Roderick; Tonya Bates; Lisa Minter; Juan Anguita; Ignacio Juncadella; Brian J Nickoloff; I Caroline Le Poole; Lucio Miele; Barbara A Osborne
Journal:  J Immunol       Date:  2011-06-17       Impact factor: 5.422

Review 6.  Th17 cell based vaccines in mucosal immunity.

Authors:  Pawan Kumar; Kong Chen; Jay K Kolls
Journal:  Curr Opin Immunol       Date:  2013-05-10       Impact factor: 7.486

7.  In vivo anti-LAP mAb enhances IL-17/IFN-γ responses and abrogates anti-CD3-induced oral tolerance.

Authors:  Andre P da Cunha; Henry Y Wu; Rafael M Rezende; Tyler Vandeventer; Howard L Weiner
Journal:  Int Immunol       Date:  2014-09-06       Impact factor: 4.823

8.  Immunomodulation By Subchronic Low Dose 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Experimental Autoimmune Encephalomyelitis in the Absence of Pertussis Toxin.

Authors:  Eun-Ju Yang; John V Stokes; Evangel Kummari; Jeffrey Eells; Barbara L F Kaplan
Journal:  Toxicol Sci       Date:  2016-01-27       Impact factor: 4.849

9.  Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune disease.

Authors:  Martin S Weber; Mahdia Benkhoucha; Klaus Lehmann-Horn; Deetje Hertzenberg; Johann Sellner; Marie-Laure Santiago-Raber; Michel Chofflon; Bernhard Hemmer; Scott S Zamvil; Patrice H Lalive
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

10.  Expression of interleukin-17RC protein in normal human tissues.

Authors:  Dongxia Ge; Zongbing You
Journal:  Int Arch Med       Date:  2008-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.